Stem Cells & Cell Differentiation: Potency, iPSCs & Medical Applications | Cambridge AS-Level Biology (9700)


Master  Stem Cells & Cell Differentiation: Potency, iPSCs & Medical Applications | Cambridge AS-Level Biology (9700)

This lesson is crafted to meet the rigorous Cambridge AS- A Level Biology (9700)  followed by top-tier institutions like British International School of Tbilisi (Georgia, Europe),  The British School of Brussels - BSB (Belgium),  Byron College (Athens, Greece) St. Julian's School (Lisbon, Portugal) King's College, The British School of Madrid (Spain) , Harrow International School (Hong Kong / Bangkok), these resources are designed to simplify complex concepts and guarantee top grades in your board examinations.

​​Before diving into Stem Cells & Cell Differentiation: Potency, iPSCs & Medical Applications | Cambridge AS-Level Biology (9700) ensure you have gone through our previous guide : Cambridge A-Level Biology | Allergies & Hypersensitivity: Mechanism, IgE Antibodies, and Immune Response

Table of Content

  • Introduction: ​What is a stem cell?
  • ​Potency Hierarchy
    • ​Totipotent vs Pluripotent vs Multipotent vs Unipotent
    • ​Embryonic Stem Cells Vs adult Stem Cells.
  • ​Medical Applications:
    • ​Bone marrow transplant for Leukemia.
    • ​Tissue repair & regenerative medicine.
  • ​Advanced Concept (A2 / Section 19 Focus):
    • ​iPSCs (Induced Pluripotent Stem Cells): Reprogramming somatic cells using transcription factors.
  • ​Ethical Debate & Social Considerations:
    • ​Embryonic Stem Cells (ESC) vs iPSCs (Destruction of blastocysts vs non-destructive alternative).
  • AO1 Knowledge with Understanding (Direct & Recall Questions)
  • AO2 Application of Knowledge (Diagram & Labeling Questions)
  • AO3 Experimental Skills & Data Interpretation (Graph & Table Questions)
Introduction: ​What is a stem cell?
  • Stem cells are undifferentiated biological cells that have the unique ability to continuously divide through mitosis and differentiate into specialized cell types.
  • Ernest McCulloch and James Till are widely credited with pioneering stem cell discovery in medical research.
  • Broadly, stem cells are categorized into two main types: Embryonic Stem Cells (ESCs) and Adult Stem Cells.
๐Ÿ’ก​Related study to understand about the  A-Level Biology: Infectious Disease – Malaria (Causes, Transmission & Control)

Potency Hierarchy
  • ​The differentiation capacity of a stem cell depends on its potency level. Stem cells are categorized into four distinct potency levels:
Totipotent vs Pluripotent vs Multipotent vs Unipotent
  • Totipotent Cells can differentiate into any cell type in the body, as well as extra-embryonic tissues (such as the placenta). Example: Early embryonic cells (Zygote up to early morula).
  • Pluripotent Cells are  capable of giving rise to almost all cell types derived from the three germ layers (ectoderm, mesoderm, and endoderm), but cannot form extra-embryonic tissues. Example: Inner cell mass of the blastocyst (Embryonic Stem Cells).
  • Multipotent Cells are  restricted to differentiating into a limited range of specialized cell types belonging to a specific lineage or tissue. Example: Hematopoietic stem cells in the bone marrow (which form red blood cells, white blood cells, and platelets).
  • Unipotent Stem cells  can divide to produce only one specific cell type, yet retain self-renewal properties. Example: Epidermal stem cells producing skin cells.
Stem Cell Potency Hierarchy Totipotent Pluripotent Multipotent Diagram
Figure: Hierarchy of Stem Cell Potency — From Totipotent (Zygote & Morula) to Pluripotent (Inner Cell Mass of Blastocyst) and Multipotent lineage differentiation.


Embryonic Stem Cells ( ESC) Vs adult Stem Cells.( Somatic stem cells)
  • Embryonic stem cells are isolated from the inner cell mass of the blastocyst during early embryonic development.
  • ESCs are pluripotent. They have the capability to differentiate into almost any cell type derived from the three primary germ layers: ectoderm, mesoderm, and endoderm.
  • ​ESC has  great Differentiation Potential and  can give rise to more than 200 distinct specialized cell types in the human body.
  • Adult stem cells are undifferentiated cells found among specialized tissues in a fully developed organism, as well as in umbilical cord blood.
  • Unlike embryonic stem cells, most naturally occurring adult stem cells are multipotent, meaning their differentiation is restricted to specific cell lineages related to their tissue of origin.
  • Key Example  include hematopoietic stem cells (forming blood cells), mesenchymal stem cells, and endothelial stem cells.
FeatureEmbryonic Stem Cells (ESCs)Adult / Somatic Stem Cells
SourceInner cell mass of the blastocyst (early stage embryo)Specialized tissues in mature organisms & umbilical cord blood
Potency LevelPluripotent (Can form all body cell types)Multipotent (Restricted to specific cell lineages)
Differentiation PotentialCan differentiate into >200 distinct cell types (Ectoderm, Mesoderm, Endoderm)Limited to specialized cells of their tissue of origin (e.g., blood, skin)
Lab Culturing & GrowthEasy to isolate and can divide indefinitely in lab culturesRare, difficult to isolate, and limited capacity for self-renewal
Immune Rejection RiskHigher risk of immune rejection if genetically non-matchingLower risk if autologous (harvested from the patient's own body)
Ethical ConcernsHigh (Requires destruction of human blastocysts)Low (Non-destructive, harvested with consent)
Medical Applications & Regenerative Medicine
  • ​Stem cell therapy (regenerative medicine) involves introducing healthy stem cells into damaged tissues to treat diseases, repair injuries, and restore biological function through controlled cell culture techniques.
Bone marrow transplant for Leukemia
  • In Current Clinical Uses, Stem cells harvested from bone marrow and umbilical cord blood are routinely used to treat blood cancers, such as leukemia and lymphoma.
  • In ​Autoimmune Conditions, They are also used in managing severe autoimmune diseases, including rheumatoid arthritis and multiple sclerosis.

Tissue repair & regenerative medicine
  • Advanced stem cell research promises revolutionary therapies for spinal cord injuries, neurodegenerative brain damage, myocardial infarction (heart damage), and type 1 diabetes. 
  • Stem cells also serve as essential tools in genetic research and targeted drug discovery.
​Advanced Concept (A2 / Section 19 Focus):
  • Induced Pluripotent Stem Cells (iPSCs) are fully differentiated adult somatic cells (such as skin fibroblasts) that have been genetically reprogrammed to re-enter a pluripotent state, behaving almost identically to embryonic stem cells (ESCs).
๐Ÿ› ️ How Are iPSCs Created? (The Reprogramming Process)
  • The creation of iPSCs involves major four steps : 
​Step 1 : Isolation: 
  • Adult somatic cells (e.g., skin cells) are harvested from a patient.
​Step 2 : Introduction of Transcription Factors: 
  • Specific genes encoding master transcription factors (commonly Oct4, Sox2, Klf4, and c-Myc—known as Yamanaka factors) are introduced into the somatic cells using viral vectors (such as retroviruses or lentiviruses).
​Step 3 : Reactivation of Pluripotency: 
  • These transcription factors alter gene expression by switching off differentiation markers and reactivating genes responsible for pluripotency and self-renewal.
​Step 4 : Differentiation: 
  • The resulting iPSCs can then be stimulated with specific signaling molecules to differentiate into any required specialized cell type (e.g., cardiomyocytes, neurons).
 
Induced Pluripotent Stem Cells iPSCs Reprogramming Yamanaka Factors Diagram
Figure: Reprogramming adult somatic cells into iPSCs using Yamanaka transcription factors (Oct4, Sox2, Klf4, c-Myc).


Key Advantages of iPSCs in Medicine
  • ​In Overcoming Immune Rejection, Since iPSCs are derived directly from the patient’s own tissues (autologous cells), they do not trigger an immune response upon transplantation.
  • ​In Disease Modeling & Drug Testing,  Scientists can create patient-specific iPSCs to study complex genetic diseases in lab dishes (e.g., Parkinson's disease) and test drug toxicity safely.

Ethical Debate & Social Considerations:
  • The use of stem cells in research and clinical therapies raises significant ethical, moral, and social questions. 
  • The primary debate centers on the source of the stem cells, specifically comparing Embryonic Stem Cells (ESCs) with Induced Pluripotent Stem Cells (iPSCs).
​1. The Ethical Controversy Surrounding Embryonic Stem Cells (ESCs)
  • ​Destruction of Human Blastocysts: ESCs are harvested from the inner cell mass of 4-to-5-day-old human blastocysts (often surplus embryos from IVF treatments). 
  • Extracting these cells destroys the embryo, raising moral concerns regarding the status of human life at the embryonic stage.
​Consent & Commercialization: 
  • Concerns exist regarding whether proper informed consent was obtained from donors, as well as the potential risk of commercializing human biological materials.
​Risk of Tumor Formation (Teratomas): 
  • ESCs divide rapidly and unpredictably; if not fully differentiated before transplantation, they pose a risk of forming benign tumors known as teratomas in patients.
2. iPSCs as an Ethical Alternative
Non-Destructive Sourcing: 
  • Induced Pluripotent Stem Cells (iPSCs) are created by reprogramming adult somatic cells (like skin or blood cells). No human embryos are destroyed in the process, resolving the core moral conflict associated with ESCs.
​Patient-Specific Treatment (Autologous Transplantation): 
  • Because iPSCs are derived from the patient's own tissue, they carry a significantly lower risk of immune rejection, reducing the need for immunosuppressive drugs.
​Limitations: 
  • While iPSCs offer an ethical breakthrough, challenges remain regarding the safety of viral vectors used in genetic reprogramming and the potential reactivation of oncogenes (cancer-causing genes like c-Myc).
AspectEmbryonic Stem Cells (ESCs)Induced Pluripotent Stem Cells (iPSCs)
Embryo DestructionYes (Blastocyst is destroyed)No (Derived from adult skin/somatic cells)
Moral / Ethical ConflictHigh (Embryonic life ethical debate)Minimal / Very Low
Immune Rejection RiskHigh (Requires immunosuppressive drugs)Low (Patient-specific / Autologous match)
Primary Safety ConcernTeratoma (tumor) formation if undifferentiatedViral vector safety & potential oncogene activation
Conclusion: The Future of Stem Cell Research
  • Stem cell technology represents one of the most promising frontiers in modern biology and regenerative medicine. 
  • By bridging the gap between basic cell biology and therapeutic applications, stem cells offer unprecedented potential to treat previously incurable conditions—from neurodegenerative disorders to genetic diseases.
  • While Embryonic Stem Cells (ESCs) provide vital insights into developmental biology, breakthroughs like Induced Pluripotent Stem Cells (iPSCs) have opened ethical and patient-specific avenues for medical treatment.
  • As genetic engineering and bioprinting technologies advance, stem cells will continue to play a pivotal role in personalizing healthcare and transforming the future of clinical medicine.

๐Ÿ“AO1 Knowledge with Understanding (Direct & Recall Questions)

Qestion 1 . Define the term stem cell and state two fundamental properties that distinguish stem cells from specialized cells. [3 Marks]
​Answer: Definition: A stem cell is an undifferentiated cell capable of continuous cell division through mitosis.
Property 1 (Self-renewal): Ability to continuously divide while maintaining an undifferentiated state.
Property 2 (Differentiation): Potential to specialize/differentiate into specialized cell types under specific signaling conditions.
Question 2. Distinguish between totipotent and pluripotent stem cells, giving one example of where each can be found. [4 Marks]
​Answer: Totipotent cells: Can differentiate into any cell type in the human body plus extra-embryonic tissues (e.g., placenta).
​Example: Early zygote or morula cells.
Pluripotent cells: Can differentiate into almost all specialized body cell types derived from the three germ layers (ectoderm, mesoderm, endoderm), but cannot form extra-embryonic tissues/placenta.
Example: Inner cell mass of the blastocyst (Embryonic Stem Cells).
Question 3. Outline the key steps involved in creating Induced Pluripotent Stem Cells (iPSCs) from adult somatic cells. [3 Marks]
​Answer: Adult somatic cells (e.g., skin fibroblasts) are isolated from a tissue donor/patient.

​Specific master transcription factor genes (such as Oct4, Sox2, Klf4, and c-Myc) are introduced into the cells using viral vectors (e.g., retroviruses).
Expression of these transcription factors reprograms the genome, reactivating pluripotency genes and returning the cells to an undifferentiated pluripotent state.
Question 4. State two clinical applications of adult stem cells currently used in medical treatments, and explain one ethical advantage of adult stem cells over embryonic stem cells (ESCs). [3 Marks]
​Answer: Clinical Applications (Any 2):
​Bone marrow transplantation to treat blood disorders/cancers (e.g., leukemia or lymphoma).
Treatment of severe autoimmune diseases (e.g., rheumatoid arthritis, multiple sclerosis).
Ethical Advantage: Adult stem cells are harvested non-destructively with patient consent, whereas harvesting ESCs requires the destruction of human blastocysts/embryos

๐Ÿ“AO2 Application of Knowledge (Diagram & Labeling Questions

Context : The diagram below outlines the process of reprogramming adult somatic cells (fibroblasts) into Induced Pluripotent Stem Cells (iPSCs) using viral vectors.


Question 1: Identify the group of biomolecules represented by labels X, Y, Z, and W. [1 Mark]


Question 2 : State the specific names of any TWO factors from X, Y, Z, or W used in this reprogramming process. [2 Marks]


Question 3 : Explain the role of retroviruses in this process and state ONE potential safety risk associated with using retroviral vectors. [2 Marks]


Answer 1 : Transcription factors (or Yamanaka factors / master gene regulatory proteins). [1 Mark]


Answer 2 : Any TWO of the following: Oct4, Sox2, Klf4, c-Myc. [2 Marks]


Answer 3 : Role: Retroviruses act as vectors to insert/integrate the genes encoding the transcription factors into the host cell genome. [1 Mark]

Safety Risk: Retroviruses can cause insertional mutagenesis (disrupting essential host genes or activating proto-oncogenes), which may lead to cancer/tumor formation. [1 Mark]


Context 2 : The diagram below illustrates a stem cell culture giving rise to various specialized cell types and tissues across different organ systems.



Question 1 : Based on the ability of these stem cells to differentiate into cells of the nervous system, digestive system, circulatory system, and skeletal system, state the potency level of the cultured stem cells shown. [1 Mark]


Question 2 : Identify the primary embryonic germ layers represented by the tissue labels P, Q, R, and S. [4 Marks] ​P (Brain / Neuron): ____ ​Q (Intestine / Enterocytes): ____ ​R (Bone / Osteocyte): ____ ​S (Heart / Cardiac cells): ____


Answer 3 : Differentiate between adult stem cells found in the brain (neural stem cells) and those found in the bone marrow (hematopoietic stem cells). [3 Marks]

​ ​Answer 1 : Pluripotent (or Pluripotency). [1 Mark] ​

Answer 2 : P (Brain / Neuron): Ectoderm [1 Mark] ​Q (Intestines / Enterocytes): Endoderm [1 Mark] ​R (Bone / Osteocyte): Mesoderm [1 Mark] ​S (Heart / Cardiac cells): Mesoderm [1 Mark]


Answer 3 : While both are multipotent adult stem cells, neural stem cells originate from the ectoderm and are localized within specific niches of the central nervous system (such as the hippocampus). They are developmentally committed to producing only neural cell lineages, including neurons, astrocytes, and oligodendrocytes, and exhibit a very low natural regenerative rate in adults.

​In contrast, hematopoietic stem cells in the bone marrow originate from the mesoderm and are lineage-restricted to forming blood cells, including red blood cells, white blood cells, and platelets. Unlike neural stem cells, hematopoietic stem cells possess a significantly higher rate of active self-renewal and continuous cell division to constantly replenish blood cells in the body.

๐Ÿš€ Join the Community! Get access to FREE Worksheets, PDF Notes, and discuss Lessons with experts and fellow students

๐Ÿš€ Join the Community! ​Get access to FREE Worksheets, PDF Notes, and discuss Lessons with experts and fellow students


๐Ÿ“AO3 Experimental Skills & Data Interpretation (Graph & Table Questions)

Context : A team of researchers investigated the effect of different combinations of Yamanaka transcription factors on the reprogramming efficiency of adult human skin fibroblasts into Induced Pluripotent Stem Cells (iPSCs). ​
In the experiment, equal numbers of fibroblasts 1 × 10⁵ cells) were transduced using retroviral vectors containing different factor combinations. The cells were cultured under identical conditions for 14 days, and the number of fully reprogrammed pluripotent stem cell colonies was recorded. ​
The results are summarized in the table and graph below:

Treatment GroupTranscription Factors IntroducedInitial Cell CountNumber of iPSC Colonies FormedReprogramming Efficiency (%)
ControlNone (Empty Retrovirus)100,00000.00%
Group AOct4 + Sox2100,000120.012%
Group BOct4 + Sox2 + Klf4100,0001800.18%
Group COct4 + Sox2 + Klf4 + c-Myc100,0001,250[ Calculate in Q3(b) ]


Question 1 : Identify the independent variable and dependent variable in this experiment.

Answer 1 : Independent Variable: The combination/number of transcription factors introduced (or type of gene treatment). ​Dependent Variable: Number of iPSC colonies formed / Reprogramming efficiency (%).


Question 2 : Calculate the reprogramming efficiency (%) for Group C.

Answer 2 : Reprogramming efficiency (%) =
No of iPSC colony formed X 100 / initial cell count
= 1250 X100/ 100000 = 12.5 %

Question 3:  With reference to the data, describe the trend shown when adding c-Myc to the combination of Oct4, Sox2, and Klf4 (Group B vs. Group C).
Answer 3 : Description: Adding c-Myc (Group C) significantly increases the reprogramming efficiency compared to using 3 factors alone (Group B). [1 Mark] ​Data Reference: Efficiency increases from 0.18% to 1.25% (an increase of 1.07% percentage points or approximately 6.9 times higher yield)

Question 4 :  Explain why retroviruses were used as vectors in this experiment, and state TWO variables that must be kept constant to ensure valid results.
Answer 4 : Role of Retrovirus: Acts as a biological vector to integrate foreign transcription factor genes into the host cell genome.
Controlled Variables (Any 2): 
​Initial number of skin fibroblasts 1 × 10⁵ cells
​Incubation temperature (e.g., 37 degree Celsius.
​Culture medium composition / growth factor concentration.
​Duration of culture period (14 days).

This module is developed by Grip the Biology for NEET Biology, IGSCE & IB  Biology students. Search "Grip the  Biology" on Google for more resources.

๐ŸŽฏ Take Your Biology Prep to the Next Level! ​

Struggling with complex Cambridge 9700/AP Biology data evaluation, graphs, or past papers? 

Don't worry, you don't have to study alone. ​Book a Free 1-on-1 Live Whiteboard Demo Session with me. 

We will break down tough concepts together in real-time.​๐Ÿ‘‡ Click the WhatsApp button below right now to claim your free slot!

๐Ÿš€ Next Steps

More Biology Hub Pages !

❓ In case of any doubt, Chat Directly: ๐Ÿ’ฌ Ask Your Doubt on WhatsApp

Share with the Friends ๐Ÿ™‚

Comments